Induction of labour, defined as stimulation of uterine contractions be
fore the spontaneous onset of labour, is indicated when the condition
of the mother or fetus precludes awaiting the onset of spontaneous lab
our. In current medical practice, induction of labour comprises 2 phas
es: cervical priming and induction of contractions. Although numerous
agents have been used for cervical priming, the current standard of ca
re is the use of intracervical or intravaginal prostaglandin E-2. The
only drug currently used for induction of contractions is intravenous
oxytocin. While many protocols are deemed acceptable, when required, t
he use of cervical priming, amniotomy and intravenous oxytocin are adv
ocated. Utilising this approach, rapid delivery can be obtained in the
majority of women.